Correlation Between Nausea and Fever in COVID-19
While nausea and fever commonly co-occur in COVID-19 patients, they typically present together as part of a constellation of symptoms rather than as isolated paired findings, with the majority of patients experiencing multiple concurrent respiratory and systemic symptoms. 1
Symptom Co-occurrence Patterns
The evidence demonstrates that gastrointestinal symptoms like nausea rarely occur in isolation in COVID-19:
Nausea/vomiting occurs in approximately 5-10% of COVID-19 patients, with reported ranges from 1.0% to 10.1% across cohort studies, and up to 10.2% in a meta-analysis of 4,243 patients. 1
Fever is among the most common presenting symptoms alongside dyspnea, cough, and chest pain in COVID-19 patients. 1
The critical finding is that patients with nausea or vomiting predominantly present with accompanying typical COVID-19 symptoms (fever, cough, shortness of breath) rather than gastrointestinal symptoms alone. 1
In hospitalized children specifically, fever and nausea/vomiting are listed together among the most common signs and symptoms, suggesting frequent co-presentation in this population. 1
Clinical Significance of the Relationship
When nausea occurs, it functions as part of the broader systemic inflammatory response rather than as a direct correlate of fever:
Patients with any gastrointestinal symptoms (including nausea, vomiting, abdominal pain, and diarrhea) were more likely to have illness duration of 1 week or longer (33%) compared to patients without GI symptoms (22%). 1
In some cases, nausea and other GI symptoms preceded the development of typical COVID-19 respiratory symptoms by a few days, suggesting they may be early manifestations of systemic infection. 1
The prevalence of nausea as the only presenting symptom in the absence of other COVID-related symptoms (including fever) was very low among hospitalized patients. 1
Practical Clinical Approach
For outpatients presenting with new-onset nausea, you must:
Obtain detailed history of high-risk contact exposure and systematically assess for fever, cough, shortness of breath, chills, muscle pain, headache, sore throat, and new loss of taste or smell. 1
Monitor for development of fever and other COVID-19 symptoms over the subsequent days, as GI symptoms may precede respiratory manifestations. 1
Consider COVID-19 testing in high-prevalence settings when nausea presents with fever or other systemic symptoms. 1
For hospitalized patients with suspected or confirmed COVID-19:
Obtain thorough history of all GI symptoms (nausea, vomiting, abdominal pain, diarrhea) including onset, characteristics, duration, and severity in relation to fever and respiratory symptoms. 1
Evaluate for treatment-related GI adverse effects from COVID-19 medications, as drugs like lopinavir/ritonavir can cause nausea, vomiting, and diarrhea in 4-28% of patients. 2
Important Caveats
The reported prevalence rates may not reflect true population-level correlation because most studies focused on hospitalized patients with more severe disease, potentially overestimating or underestimating the actual relationship between nausea and fever in milder cases. 1
Drug-induced symptoms can confound the clinical picture, as multiple COVID-19 treatments cause both fever and nausea as side effects, making it difficult to distinguish disease manifestations from medication effects. 2